[Skip to Content]
[Skip to Content Landing]
Article
June 29, 1918

UNRIGHTEOUS PROFITS IN PATENTED PRODUCTS

Author Affiliations

New Paris, Ohio.

JAMA. 1918;70(26):2047. doi:10.1001/jama.1918.02600260059018

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:  —In line with Dr. Bevan's address in regard to leaving German scientists and preparations alone and using American, I will state that "Aspirin Bayer" decreased in price from $8.80 to $4.40 per thousand at the time their patent expired, about eighteen months ago. The foregoing were prices I paid at that time, being a retail druggist. Physicians, not druggists, paid more. They were charging $4.40 per thousand above legitimate profit or they would not have reduced the price that amount when their protection expired. I wonder how many millions of these $4.40 went to help the kaiser.The government should protect a patentee (if not a Hun) but should not allow him to collect cost plus a legitimate profit and then double the charge.

First Page Preview View Large
First page PDF preview
First page PDF preview
×